Amphastar Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Amphastar Pharmaceuticals, Inc. (AMPH) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $107.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2018-03-14
- Amphastar Pharmaceuticals, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $107.00K, a 90.35% decline from fiscal 2014.
- Amphastar Pharmaceuticals, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $1.11M, a 71.41% increase from fiscal 2013.
- Amphastar Pharmaceuticals, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $647.00K, a 439.17% increase from fiscal 2012.
- Amphastar Pharmaceuticals, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2012 was $120.00K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2015-12-31 | $107.00K 10-K · filed 2018-03-14 |
| 2014-12-31 | $1.11M 10-K · filed 2015-03-26 |
| 2013-12-31 | $647.00K 10-K · filed 2015-03-26 |
| 2012-12-31 | $120.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |